Table 4.
Full Model |
Final Model |
|||
---|---|---|---|---|
Adjusted OR (95% CI) | P-Value | Adjusted OR (95% CI) | P-Value | |
Age (per 1-year increase) | 0.98 (0.97, 0.99) | 0.004 | 0.98 (0.97, 0.99) | 0.005 |
Male (reference = female) | 0.56 (0.38, 0.83) | 0.004 | 0.56 (0.38, 0.82) | 0.003 |
Black (reference = white) | 1.00 (0.46, 2.18) | 1.00 | ||
Latino (reference = white) | 1.06 (0.48, 2.34) | 0.88 | ||
Other/unknown race (reference = white) | 1.19 (0.50, 2.81) | 0.69 | ||
Eosinophil count at time of SARS-CoV-2 test (per 0.1 K/μL increase in eosinophils) | 0.09 (0.01, 0.95) | 0.046 | 0.10 (0.01, 0.97) | 0.047 |
History of hypertension (reference = no) | 1.08 (0.66, 1.77) | |||
History of hypercholesterolemia (reference = no) | 1.12 (0.68, 1.85) |
*Hosmer-Lemeshow goodness of fit test: p = 0.42 for full model; p = 0.09 for final model.
Full model includes past medical history and laboratory variables with sufficient available data and p < .05 for association with anosmia or ageusia at the bivariate level, as well as demographic characteristics. Final model includes variables with p-value < .05 after applying stepwise backward selection.p<0.05 are shown in bold and italic format.